Skip to main content
. 2023 Apr 27;9(6):841ā€“846. doi: 10.1001/jamaoncol.2023.0187

Table 1. Patient Characteristics Among the GOM Neoadjuvant Cohort (Nā€‰=ā€‰155).

Characteristic No. (%)
Pathological response in breast and axilla
Complete response 89 (57.4)
Residual disease 66 (42.6)
Hormone receptor status
Positive 105 (67.7)
Negative 50 (32.3)
Intrinsic subtype
Luminal A 38 (24.5)
Luminal B 26 (16.8)
ERBB2 enriched 80 (51.6)
Basallike 8 (5.2)
Normallike 3 (1.9)

Abbreviation: GOM, GOM-HGUGM-2018-05 trial.